Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01702805 · ClinicalTrials.gov registry record · NA
Transfusion of Prematures Trial
A NA study of Anemia and Infant, Small for Gestational Age, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- NA
- Development phase
- 1,824
- Enrollment target
- 20
- Study locations
NCT01702805 is a NA study of Anemia and Infant, Small for Gestational Age that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 1,824 participants, above the 402-participant average among 72 other Anemia trials with a reported enrollment target (354% higher). The trial reports 20 study locations across 15 states.
The verdict
NCT01702805, a NA study of Anemia and Infant, Small for Gestational Age, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,824 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the TOP trial is to determine whether higher hemoglobin thresholds for transfusing ELBW infants resulting in higher hemoglobin levels lead to improvement in the primary outcome of survival and rates of neurodevelopmental impairment (NDI) at 22-26 months of age, using standardized assessments by Bayley.
Conditions Studied
Interventions
- PROCEDURE Liberal Cell Transfusion
- PROCEDURE Restricted red cell transfusion
Study Locations (20)
Ohio
- Cincinnati Children's Medical Center - Cincinnati
- Case Western Reserve University, Rainbow Babies and Children's Hospital - Cleveland
- Research Institute at Nationwide Children's Hospital - Columbus
California
- University of California - Los Angeles - Los Angeles
- Stanford University - Palo Alto
North Carolina
- RTI International - Durham
- Duke University - Durham
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
- University of Texas Health Science Center at Houston - Houston
Alabama
- University of Alabama at Birmingham - Birmingham
Georgia
- Emory University - Atlanta
Indiana
- Indiana University - Indianapolis
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,824 participants |
| Start Date | 2012-12 |
| Est. Completion | 2025-04-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01702805
The ClinicalTrials.gov registry entry for NCT01702805 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,824 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 402-participant average among 72 other Anemia trials with a reported enrollment target (354% higher). The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which Liberal Cell Transfusion is the first listed.
NCT01702805 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Ohio, California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01702805 about?
NCT01702805 is a clinical study titled "Transfusion of Prematures Trial". The objective of the TOP trial is to determine whether higher hemoglobin thresholds for transfusing ELBW infants resulting in higher hemoglobin levels lead to improvement in the primary outcome of survival and rates of neurodevelopmental impairment (NDI) at 22-26 months of age, using standardized as...
What is the current status of trial NCT01702805?
This trial is currently completed. It is a NA study. The enrollment target is 1,824 participants. The study started on 2012-12. Estimated completion is 2025-04-29.
What conditions does trial NCT01702805 study?
This clinical trial studies the following conditions: Anemia, Infant, Small for Gestational Age, Infant, Newborn, Diseases, Bronchopulmonary Dysplasia (BPD), Infant, Extremely Low Birth Weight.
What interventions are being tested in trial NCT01702805?
The interventions under investigation include: Liberal Cell Transfusion (PROCEDURE), Restricted red cell transfusion (PROCEDURE).
Who is sponsoring clinical trial NCT01702805?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01702805 being conducted?
This trial has 20 study locations across Alabama, California, Georgia, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
-
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
RECRUITING · NA
-
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
RECRUITING · NA
-
The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
ACTIVE NOT RECRUITING · NA
-
Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia
ACTIVE NOT RECRUITING · NA
-
Placental Transfusion in Term Infants: A Pilot Study
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.